Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | BioSig Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
Di | BioSig Technologies appoints new CEO | 1 | MassDevice | ||
Di | BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately | 27 | GlobeNewswire (Europe) | Westport, CT, April 30, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) or ("BioSig" or "the Company"), a medical technology Company delivering unprecedented accuracy and precision... ► Artikel lesen | |
17.04. | Lexaria Bioscience, Biosig Technologies, BIMI Holdings among healthcare movers | 1 | Seeking Alpha | ||
16.04. | BioSig Technologies, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
16.04. | JAGX, BSGM and SXTC among mid-day movers | 48 | Seeking Alpha | ||
15.04. | BSGM, ENLV and WISA among mid-day movers | 2 | Seeking Alpha | ||
11.04. | HYMC, BSGM and ADIL are among premarket gainers | 11 | Seeking Alpha | ||
10.04. | Aptevo Therapeutics, TRACON Pharmaceuticals, Biosig Technologies among healthcare movers | 10 | Seeking Alpha | ||
10.04. | BSGM, WAVE and TCBP among pre-market losers | 3 | Seeking Alpha | ||
04.04. | BioSig Technologies, Inc.: BioSig Engages Consulting Firm for Business Model Strategies | 4 | GlobeNewswire (USA) | ||
02.04. | BioSig Technologies, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
11.03. | BioSig faces potential Nasdaq delisting over equity shortfall | 2 | Investing.com | ||
11.03. | BioSig Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
21.02. | BioSig Technologies, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
21.02. | Fast Five: Medtronic exits ventilator market; BioSig reduces workforces again, will 'substantially' cut operations | 6 | MassDevice | ||
20.02. | BioSig Technologies Terminates Significant Number Of Employees | 1 | RTTNews | ||
20.02. | BioSig reduces workforce again, will 'substantially' cut operations | 1 | MassDevice | ||
20.02. | BioSig cuts workforce, scales back operations | 1 | Investing.com | ||
20.02. | BioSig Technologies, Inc.: BioSig Announces Reduction of its Workforce | 361 | GlobeNewswire (Europe) | Westport, CT, Feb. 20, 2024 (GLOBE NEWSWIRE) -- -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company, today announced that it has terminated a significant... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ORPEA | 13,282 | +4,25 % | ORPEA: emeis Sells a Real-Estate Portfolio in the Netherlands Worth a Total Value of Around €97 Million | Regulatory News:
ORPEA (Paris:ORP):
emeis announces that it has signed an agreement to sell a real estate portfolio of eleven nursing homes in the Netherlands to Bouwinvest for a total deed-in-hand... ► Artikel lesen | |
NANO-X IMAGING | 9,240 | +0,98 % | Nano-X Imaging LTD.: Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold | - According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average - Findings... ► Artikel lesen | |
BUTTERFLY NETWORK | 0,919 | 0,00 % | Butterfly Network Reports First Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound... ► Artikel lesen | |
GOODRX | 7,010 | 0,00 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen | |
JOINT CORP | 12,860 | +0,39 % | The Joint Corp. Reports Fourth Quarter and Year-end 2023 Financial Results | - Grew 2023 Revenue 16%, System-wide Sales 12%, and System-wide Comp Sales 4% vs. 2022 - - Increased Clinic Count to 935 at Year-end 2023, Initiating Refranchising Program - SCOTTSDALE, Ariz., March... ► Artikel lesen | |
CARMAT | 2,900 | -3,33 % | CARMAT: Availability of the 2023 Universal Registration Document | Regulatory News:
CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from... ► Artikel lesen | |
HYPERFINE | 0,785 | -0,63 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
PROGYNY | 32,070 | 0,00 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
MIMEDX | 7,500 | +2,74 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial Results | Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management... ► Artikel lesen | |
BIOMERICA | 0,600 | 0,00 % | Biomerica jumps on signing multi-year distribution deal with major UAE healthcare company | ||
ATRION | 396,00 | +1,54 % | Dividendenbekanntmachungen (14.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PLC GB00BF8Q6K64 0,073 GBP 0,0853 EUR ABRDN PLC ADR US00108N1000 0,3203 USD 0,2925 EUR ACCO BRANDS CORPORATION US00081T1088 0... ► Artikel lesen | |
ATRICURE | 22,210 | -10,48 % | AtriCure Reports First Quarter 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
AMWELL | 0,520 | -2,24 % | American Well Corp reports results for the quarter ended in January - Earnings Summary | ||
OUTSET MEDICAL | 3,000 | +5,63 % | FDA labels Outset Medical recall of Tablo hemodialysis system as Class I |